Log in
Enquire now
Aurinia Pharmaceuticals

Aurinia Pharmaceuticals

Aurinia Pharmaceuticals is an Edmonton-based company developing therapies to treat patient populations suffering from disease states.

OverviewStructured DataIssuesContributors

Contents

auriniapharma.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Medical diagnostics
Medical diagnostics
Therapeutics
Therapeutics
Location
Victoria, British Columbia
Victoria, British Columbia
0
Rockville, Maryland
Rockville, Maryland
0
Edmonton
Edmonton
0
B2X
B2B
B2B
CEO
Peter Greenleaf
Peter Greenleaf
0
Founder
Neil Solomons
Neil Solomons
0
Richard Glickman
Richard Glickman
0
Pitchbook URL
pitchbook.com/profiles.../59673-52
Legal Name
Aurinia Pharmaceuticals Inc.
Number of Employees (Ranges)
201 – 500
Email Address
medinfo@auriniapharma.com0
bd@auriniapharma.com0
clinicaltrials@auriniapharma.com0
aurinia@westwicke.com0
Phone Number
+125074424870
Full Address
201-17873 – 106 A Avenue Edmonton, AB T5S 1V8 Canada0
77 Upper Rock Circle – Suite 700 Rockville, MD 20850 USA0
1203-4464 Markham Street Victoria, BC V8Z 7X8 Canada0
CIK Number
1,600,6200
Place of Incorporation
Alberta
Alberta
0
Investors
venBio
venBio
Lumira Ventures
Lumira Ventures
Founded Date
1993
Fax Number
+1 (250) 708-43450
Total Funding Amount (USD)
451,550,000
Latest Funding Round Date
December 12, 2019
Competitors
AbCellera Biologics
AbCellera Biologics
Stock Symbol
AUP
AUPH0
Exchange
Nasdaq
Nasdaq
0
TSX Venture Exchange
TSX Venture Exchange
Board of Directors
Peter Greenleaf
Peter Greenleaf
0
‌
Brinda Balakrishnan
0
‌
George M. Milne
0
CFO
‌
Joe Miller
0
NAICS Code
325,4120
Patents Assigned (Count)
7
Country
United States
United States
0
Canada
Canada
0

Other attributes

Company Operating Status
Active
Contact Page URL
auriniapharma.com/contact-us
SIC Code
2,8340
Ticker Symbol
AUPH

Aurinia Pharmaceuticals is a clinical biopharmaceutical company that focuses on developing and commercializing therapies for treating targeted patient populations that are seriously affected by diseases with challenging medical need. Aurinia is exploring the potential of novel therapies to address patients' needs. Approved therapies include that for lupus nephritis, and they are in the process of pursuing a wider portfolio of innovative drugs for autoimmune disease.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Aurinia Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.